We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Top Buys

1
TSEM icon
Tower Semiconductor
TSEM
+$9.09M
2
LITE icon
Lumentum
LITE
+$8.24M
3
GLW icon
Corning
GLW
+$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Top Sells

1
CNC icon
Centene
CNC
+$9.07M
2
MOH icon
Molina Healthcare
MOH
+$8.9M
3
ELV icon
Elevance Health
ELV
+$8.08M
4
BTSG icon
BrightSpring Health Services
BTSG
+$3.52M
5
TERN
Terns Pharmaceuticals
TERN
+$2.78M

Sector Composition

1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MANE
101
Veradermics Inc
MANE
$4.65B
$580K 0.22%
+9,191
New +$464K
MNSO icon
102
MINISO
MNSO
$3.81B
$559K 0.21%
34,523
-1,774
-5% -$32.5K
BCYC
103
Bicycle Therapeutics
BCYC
$294M
$559K 0.21%
+120,437
New +$688K
EW icon
104
Edwards Lifesciences
EW
$49.3B
$554K 0.21%
6,915
+1,154
+20% +$95.1K
CELC icon
105
Celcuity
CELC
$4.31B
$553K 0.21%
4,843
-1,876
-28% -$205K
INDV icon
106
Indivior Pharmaceuticals
INDV
$4.79B
$549K 0.2%
18,012
+13,482
+298% +$445K
RRC icon
107
Range Resources
RRC
$8.66B
$542K 0.2%
+11,734
New +$457K
CLYM
108
Climb Bio
CLYM
$727M
$495K 0.18%
72,325
+63,097
+684% +$364K
RBRK icon
109
Rubrik
RBRK
$16.2B
$490K 0.18%
10,000
-6,000
-38% -$344K
TNGX icon
110
Tango Therapeutics
TNGX
$4.64B
$484K 0.18%
+23,116
New +$322K
FRO icon
111
Frontline
FRO
$8.12B
$480K 0.18%
+14,000
New +$428K
SNY icon
112
Sanofi
SNY
$107B
$479K 0.18%
9,946
+2,501
+34% +$117K
STTK icon
113
Shattuck Labs
STTK
$720M
$477K 0.18%
+74,229
New +$352K
AVR
114
Anteris Technologies
AVR
$823M
$477K 0.18%
85,913
+62,596
+268% +$360K
SMWB icon
115
Similarweb
SMWB
$609M
$470K 0.18%
180,000
– –
AMTB icon
116
Amerant Bancorp
AMTB
$1.03B
$460K 0.17%
20,874
-15,210
-42% -$327K
TARS icon
117
Tarsus Pharmaceuticals
TARS
$2.61B
$460K 0.17%
+6,556
New +$458K
ERAS icon
118
Erasca
ERAS
$6.65B
$457K 0.17%
+28,270
New +$334K
CRL icon
119
Charles River Laboratories
CRL
$10.8B
$456K 0.17%
2,643
+544
+26% +$101K
INSW icon
120
International Seaways
INSW
$4.29B
$451K 0.17%
6,364
+4,364
+218% +$279K
ISRG icon
121
Intuitive Surgical
ISRG
$122B
$450K 0.17%
977
– –
MGNX icon
122
MacroGenics
MGNX
$285M
$438K 0.16%
+151,728
New +$324K
VRTX icon
123
Vertex Pharmaceuticals
VRTX
$123B
$419K 0.16%
939
-1,727
-65% -$805K
NKTR icon
124
Nektar Therapeutics
NKTR
$2.3B
$419K 0.16%
+5,820
New +$331K
MLYS icon
125
Mineralys Therapeutics
MLYS
$2.39B
$417K 0.16%
15,401
+7,985
+108% +$234K
3 4
5
6 7

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.